---
title: 'Publisher Correction: First-line talazoparib with enzalutamide in HRR-deficient
  metastatic castration-resistant prostate cancer: the phase 3 TALAPRO-2 trial'
date: '2024-01-31'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38297094/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240201170635&v=2.18.0
source: heidelberg[Affiliation]
description: No ...
disable_comments: true
---
No ...